References
- Obeidat N, Jawdat F, Al-Bakri AG, Shehabi AA. Major biologic characteristics of Acinetobacter baumannii isolates from hospital environmental and patients’ respiratory tract sources. Am J Infect Control. 2014; 42(4):401-4. PubMed | Google Scholar
- Punpanich W, Nithitamsakun N, Treeratweeraphong
V, Suntarattiwong P.Risk factors for carbapenem non-susceptibility
and mortality in Acinetobacter baumannii bacteremia in children. Int
J Infect
Dis. 2012;16(11):e811-e815. PubMed | Google
Scholar
- Özgür ES, Horasan ES, Karaca K, Ersöz G , Atis S N, Kaya A. Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii: Risk factors, clinical features, and outcomes. Am J Infect Control. 2014; 42:206-8. PubMed | Google Scholar
- Shields RK, Kwak EJ, Potoski BA, Doi Y, Adams-Haduch JM, Silviera FP, Toyoda Y, Pilewski JM, Crespo M, Pasculle AW, Clancy CJ, Nguyen MH.High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimen. Diagn Microbiol Infect Dis. 2011;70(2):246–252. PubMed | Google Scholar
- Turkoglu M, Mirza E, Tunçcan OG, Erdem GU, Dizbay M, Yagci M, Aygencel G, Türköz Sucak G.Acinetobacter baumannii infection in patients with hematologic malignancies in intensive care unit: Risk factors and impact on mortality. J Crit Care. 2011; 26(5):460–467. PubMed | Google Scholar
- Elouennass M,Sahnoun I, Zrara A, Bajjou T, Elhamzaoui S. Épidémiologie et profil de sensibilité des isolats d’hémoculture dans un unit de réanimation (2002–2005). Med Mal Infect. 2008 ; 38(1):18-24. PubMed | Google Scholar
- Lahsoune M, Boutayeb H, Zerouali K, Belabbes H, El Mdaghri N. Prévalence et état de sensibilité aux antibiotiques d’Acinetobacter baumannii dans un CHU marocain. Med Mal Infect. 2007 ; 37 :828–831. PubMed | Google Scholar
- Ntusi NB, Badri M, Khalfey H, Whitelaw A, Oliver
S, Piercy J, Raine R, Joubert I, Dheda K. ICU-Associated Acinetobacter
baumannii Colonisation/Infection in a High HIV Prevalence Resource-Poor
Setting. PLoS One. 2012; 7(12): e52452. PubMed | Google
Scholar
- Simor AE, Lee M, Vearncombe M, Jones-Paul L, Barry
C, Gomez M, Fish JS, Cartotto RC, Palmer R, Louie M. An outbreak due
to multirésistant Acinetobacter baumannii in burn unit: Risk factors
for acquisition and management. Infect Control Hosp Epidemiol. 2002;
23 (5): 261-267. PubMed | Google
Scholar
- Vincent JL, Rello J, Marshall J, Silva E, Anzueto
A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr
Y, Reinhart K. EPIC II Group of Investigators.International Study of
the Prevalence and Outcomes
of Infection in Intensive Care Units. JAMA. 2009;302(21):2323-2329. PubMed | Google
Scholar
- García-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero
J, Jiménez-Jiménez FJ, Pérez-Paredes C, Barrero-Almodóvar AE, Gili-Miner
M. Risk Factors for Acinetobacter baumannii Nosocomial
Bacteremia in Critically Ill Patients:a Cohort Study. Clin Infect Dis.
2001; 33(7):939–46. PubMed | Google
Scholar
- Shareek PS, Sureshkumar D, Ramgopalakrishnan,
Ramasubramanian V, Ghafur KA, Thirunarayanan MA. Antibiotic
Sensitivity Pattern of Blood Isolates of Acinetobacter
Species in a Tertiary Care
Hospital: A Retrospective Analysis. Am J Infect Dis.
2012; 8 (1): 65-69. PubMed | Google
Scholar
- Somily AM, Absar MM, Arshad MZ, Al Aska AI, Shakoor ZA, Fatani AJ, Siddiqui YM, Murray TS. Antimicrobial susceptibility patterns of multidrug resistant Pseudomonas aeruginosa and Acinetobacter baumannii against carbapenems, colistin, and tigecycline. Saudi Med J. 2012; 33 (7): 750-755. PubMed | Google Scholar
- Mushtaq S, Javeid I, Hassan M.Antibiotic sensitivity
pattern of Acinetobacter species isolated from clinical
specimens in a tertiary care hospital. Biomedica. 2013;
29:23-26. PubMed | Google
Scholar
- Gerald Denys A, Steven M Callister, Michael
J Dowzicky. Antimicrobial susceptibility among gram-negative
isolates collected in the USA between 2005 and 2011
as part of the Tigecycline Evaluation
and Surveillance Trial (TEST). Ann Clin Microbiol Antimicrob.
2013; 12:24. PubMed | Google
Scholar
- Hamouche E, Sarkis DK. Évolution de la sensibilité aux
antibiotiques de Escherichia coli,Klebsiella pneumoniae,
Pseudomonas aeruginosa et Acinetobacter baumannii dans
un CHU de Beyrouth entre 2005
et 2009.Pathol Biol (Paris). 2012; 60:e15-e20. PubMed | Google
Scholar
- Xu J, Sun Z, Li Y, Zhou Q. Surveillance and Correlation of Antibiotic Consumption and Resistance of Acinetobacter baumannii complex in a Tertiary Care Hospital in Northeast China, 2003–2011. Int J Environ Res Public Health. 2013;10:1462-1473. PubMed | Google Scholar
- Al-Mously N, Hakawi A. Acinetobacter baumannii bloodstream infections in a tertiary hospital:Antimicrobial resistance surveillance. Int J Infect Control. 2013; 9 (2):1-8. PubMed | Google Scholar
- Ben Haj Khalifa A, Khedher M. Profil de sensibilité aux antibiotiques des souches d’Acinetobacter baumannii isolées dans la région de Mahdia. Med Mal Infect. 2010 ; 40 :126–128. PubMed | Google Scholar
- Jaggi N, Sissodia P, Sharma L. Acinetobacter baumannii isolates in a tertiary care hospital: Antimicrobial resistance and clinical significance. J Microbiol Infect Dis. 2012; 2(2): 57-63. PubMed | Google Scholar
- Queenan AM, Pillar CM, Deane J, Sahm DF, Lynch AS, Flamm RK, Peterson J, Davies TA. Multidrug resistance among Acinetobacter spp. in the USA and activity profile of key agents: results from Capital Surveillance 2010. Diagn Microbiol Infect Dis. 2012 ;73(3):267-70. PubMed | Google Scholar
- Elouennass M, Bajou T, Lemnouer AH, Foissaud V, Hervé V, Baaj AJ. Acinetobacter baumannii : étude de la sensibilité des souches isolées à l’hôpital militaire d’instruction MohammedV, Rabat, Maroc. Med Mal Infect. 2003; 33:361–364. PubMed | Google Scholar
- Garnacho-Montero J, Amaya-Villar R. Multiresistant Acinetobacter baumannii infections: epidemiology and management. Curr Opin Infect Dis. 2010; 23(4): 332-339. PubMed | Google Scholar
- Huang CH, Lee CL, ACM Lin, Chen WY, Teng PC,
Lee SH, Hsieh YJ, Jang TN. Different strains of Acinetobacter
baumannii spreading in an intensive care unit. JACME. 2011;1:5-10. PubMed | Google
Scholar
- Fishbain J, Peleg AY.Treatment of Acinetobacter Infections. Clin Infect Dis. 2010; 51(1):79–84. PubMed | Google Scholar
- Jung JY, Park MS, Kim SE, Park BH, Son JY, Kim EY, Lim JE, Lee SK, Lee SH, Lee KJ, Kang YA, Kim SK, Chang J, Kim YS. Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit. BMC Infect Dis 2010;10:228. Google Scholar
- Nazmul MHM, Jamal H, Fazlul MKK. Acinetobacter species-associated infections and their antibiotic susceptibility profiles in Malaysia. Biomed Res-India. 2012; 23 (4): 571-575. PubMed | Google Scholar
- Chang HC, Chen YC, Lin MC, Liu SF, Chung YH, Su MC, Fang WF, Tseng CC, Lie CH, Huang KT, Wang CC. Mortality risk factors in patients with Acinetobacter baumannii ventilator-associated pneumonia.J Formos Med Assoc. 2011;110(9):564-571. PubMed | Google Scholar
- Chuang YC, Sheng WH, Li SY, Lin YC, Wang JT, Chen YC, Chang SC. Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with Acinetobacter bacteremia. Clin Infect Dis. 2011; 52(3):352–60. PubMed | Google Scholar
- Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA.Global Challenge of Multidrug-Resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2007 ; 51(10):3471-84. PubMed | Google Scholar
- Ziglam H, Elahmer O, Amri S, Shareef F, Grera
A,Labeeb M, Zorgani A. Antimicrobial resistance patterns among Acinetobacter
baumannii
isolated from burn intensive care unit in Tripoli,
Libya. IAJAA. 2012;2 (3):1-8. PubMed | Google
Scholar
- Shrestha M, Khanal B. Acinetobacter species:
phenotypic characterization and antimicrobial resistance.
JoNMC. 2013; 2(1):43-48. PubMed | Google
Scholar
- Ko KS, Suh JY, Kwon KT, Jung SI, Park KH, Kang CI, Chung DR, Peck KR, Song JH. High rates of resistance to colistin and Polymixin B in subgroups of Acinetobacter baumannii isolates from Korea. J Antimicrob Chemother. 2007; 60(5):1163-1167. PubMed | Google Scholar
- Moffatt JH, Harper M, Harrison P, Hale JD, Vinogradov E, Seemann T, Henry R, Crane B, St Michael F, Cox AD, Adler B, Nation RL, Li J, Boyce JD. Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production. Antimicrob Agents Chemother. 2010; 4971–4977. PubMed | Google Scholar
- Adams MD, Nickel GC, Bajaksouzian S, Lavender H,
Murthy AR, Jacobs MR, Bonomo RA.Resistance to Colistin in Acinetobacter
baumannii Associated with Mutations in the PmrAB Two-Component System.
Antimicrob Agents Chemother. 2009; 53(9): 3628-3634. PubMed | Google
Scholar